In the past year, Tchaikapharma has consolidated its leading position through the successful development of numerous scientific projects, the basis of which is advanced
research work on the development and implementation of innovative combined medicinal products (polypills) that have not been applied so far in the world medical practice.
A number of successful laboratory studies and clinical trials have been conducted with extensive international involvement in close collaboration with European and American scientific societies,
mainly in the fields of cardiology, endocrinological diseases and neurology. The unique fixed-dose combination of several active ingredients results entirely on the benefit of patients whose added value includes better therapeutic results and higher cost-effectiveness. Combination drugs are attractive with their increased efficacy enabling the use of several medications in one tablet.

The full original article is available here in Bulgarian.